Clinical trial Recruiting at 1 site Interventional Ages 8 to 17

Comparing family-based telemedicine to inpatient treatment for anorexia nervosa

Official title: Family-based Telemedicine vs. Inpatient Anorexia Nervosa Treatment (FIAT)

Run by Charite University, Berlin, Germany · NCT06759402 · Data updated 2026-11-12

This study is testing if family-based treatment for anorexia nervosa delivered through telehealth is as effective as traditional inpatient care for teenagers with this condition.

More Anorexia Nervosa trials

Quick facts

Study typeInterventional
Ages8 Years to 17 Years
SexAll
Enrollment200 (estimated)
SponsorCharite University, Berlin, Germany
Academic / other
Locations1 site (Berlin, State of Berlin)
StatusRecruiting
StartedJanuary 31, 2025
Main results expectedMarch 31, 2027
Study endsDecember 31, 2027
Registry record updatedFebruary 13, 2025
Trial IDNCT06759402 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adolescents with anorexia nervosa who require inpatient treatment and have a stable internet connection.

Probably not a fit

Patients with severe weight loss, acute self-harm, or other significant psychiatric conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The FIAT study aims to evaluate the effectiveness of Family-Based Treatment (FBT) delivered through telehealth compared to traditional inpatient multimodal therapy (IMT) for patients with anorexia nervosa. Conducted across 21 hospitals in Germany, this interventional study will assess treatment outcomes and health economic data to inform future guidelines and reimbursement policies for FBT. Participants will include adolescents with restrictive and bulimic subtypes of anorexia nervosa who meet specific eligibility criteria, including a stable internet connection for telehealth participation.

Why it matters

Potential benefit: If successful, this study could provide a more accessible and effective treatment option for adolescents with anorexia nervosa.

How similar studies have gone: Other studies have shown promise in using telehealth for mental health treatments, suggesting potential success for this approach, though this specific comparison is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* restrictive and bulimic subtypes of anorexia nervosa (ICD-10: F50.00; F50.01)
* inpatient treatment indication according to S3 guideline
* weight \< 3. BMI-percentile or
* weight \<10. percentile and psychiatric comorbidity/rapid weight loss/lack of weight gain during outpatient treatment over last three month
* planned inpatient treatment
* insured with one of the participating health insurance companies
* stable internet connection

Exclusion Criteria:

* weight \<67%mBMI
* acute self harm or danger to others
* acute psychosis or suicidal tendencies
* current substance abuse
* child abuse or domestic violence in the family
* insured with other health insurance company
* judicial placement order for inpatient treatment
* known, currently existing child protection problems or proceedings by the family court

Where it's running

  • Charité- Universitätsmedizin Berlin
    Berlin, State of Berlin, Germany
    Recruiting

Study contacts

  • Principal investigator: Christoph U Correll, MD — Charite University, Berlin, Germany
  • Study coordinator: Verena K. Haas, Dr. oec. troph.
  • Email: verena.haas@charite.de
  • Phone: +4930 450 566 399

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.